CD79A and cranioectodermal dysplasia: Future research should consider the following points: the diagnosis of CeD should include serological standardized testing of TGA, EMA, and total IgA antibodies followed by confirmatory duodenal biopsy (Marsh criteria) in all seropositive patients.